Healthcare stocks were falling premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.4% lower and the iShares Biotechnology ETF (IBB) down 1%.
Moderna (MRNA) and Merck (MRK) shares declined after reports emerged about a possible leak of data on the companies' highly anticipated personalized melanoma vaccine, Bloomberg reported Thursday, citing unverified sources on X. Shares of Moderna were still down more than 4% pre-bell.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments